MedEsthetics
OCTOBER 28, 2024
Garcoa, a leading private label manufacturer, launches a new affordable brand called Daily Results, designed to help retailers of all sizes enter the private label market.
Lori Crete
OCTOBER 28, 2024
Trigger Warning: This episode discusses topics related to mental illness, sexual assault, and suicidal thoughts. Listener discretion is advised. If you or someone you know is struggling, please seek professional help or contact a mental health crisis line. Holly Eve, founder of Madame Lemy, a luxury sustainable deodorant and personal care brand, joins Lori to discuss all things manifestation, mental health, and entrepreneurship.
Dermatology Times
OCTOBER 28, 2024
The clinical trial showed promising results for patients who used probiotics as an accompanying treatment.
Pivot Point International
OCTOBER 28, 2024
LABX LIVE: Let’s Recap Pivot Point’s In-Person Learning Event for Beauty Schools Hosted by Pivot Point in Rosemont, IL, the inaugural LABX LIVE event brought together over 80 educators, school owners, and directors for an inspiring weekend packed with learning and meaningful connections. The highlight? A first look at Pivot Point’s newest educational release— Fundamentals: Cosmetology 2nd Edition The excitement kicked off with a lively Welcome Reception, where attendees mingled with fellow
Dermatology Times
OCTOBER 28, 2024
A study of the new cleanser included diverse participants, ensuring it is suitable for various skin types and sensitivities.
Lipgloss and Aftershave
OCTOBER 28, 2024
Innovative Peeling From Head to Toe Barry + Jenni are joined by Lira Clinical® Co-Founders Metaxia Dalikas and Francine Kagarakis. They will share their in-depth knowledge on chemical peels and ingredient technology. Lira Clinical® is rooted in the clinical aesthetic arena allowing the opportunity for customized treatments directed by what the skin needs.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Beauty Launchpad
OCTOBER 28, 2024
The celebrity hairstylist aims to make make hairstyling easier, less painful and stronger with his line of hair pins and ties.
Dermatology Times
OCTOBER 28, 2024
This review of the latest dermatologic studies includes discussions on the relationship between atopic dermatitis and prurigo nodularis, the use of upadacitinib for treating PN, and more.
US Dermatologt Partners
OCTOBER 28, 2024
The body changes in numerous ways during pregnancy, and that includes changes in skin’s health and appearance. According to Dr. Lauren Snitzer of U.S. Dermatology Partners Sugar Land , “Changes in skin tone, development of lesions, and skin dryness or irritation can all occur during pregnancy. While none of these changes are necessarily warning signs of anything dangerous, skin cancer and more serious conditions can also develop during pregnancy.
The Dermatology Digest
OCTOBER 28, 2024
Specialized genomic technology can enhance understanding of Marjolin’s ulcer (MU), a rare, highly aggressive skin cancer that affects chronic wounds. “The longer you live with a chronic wound the higher your risk of developing Marjolin’s ulcer,” says Dr. Jeff Biernaskie, PhD, principal investigator and Calgary Firefighters Burn Treatment Society Chair in Skin Regeneration and Wound Healing, in a news release.
Dermatology Times
OCTOBER 28, 2024
Posters at AMCP Nexus analyzed the burden of flares on patients with atopic dermatitis (AD) and the impact initiating ruxolitinib cream had on use of other therapies.
The Dermatology Digest
OCTOBER 28, 2024
Organon has completed the acquisition of Dermavant Sciences Ltd. from Roivant including tapinarof cream, 1% (Vtama, Dermavant). Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, is approved by the U.S. Food and Drug Administration (FDA) for treatment of mild, moderate, and severe plaque psoriasis in adults. The FDA is reviewing a supplemental New Drug Application (sNDA) for tapinarof cream, 1%, as a potential treatment for atopic dermatitis (AD) in adults and children two years of age
Dermatology Times
OCTOBER 28, 2024
Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.
Enlightened Beauty
OCTOBER 28, 2024
I've helped many people transform their skin, and there's one thing they're all shocked to learn: that persistent acne and premature aging might have less to do with your skincare routine and more to do with what's happening inside your body. After a decade as a holistic esthetician specializing in acne and inflammation, I've seen firsthand how one sneaky ingredient is sabotaging your skin goals – sugar.
Expert insights. Personalized for you.
78 
Let's personalize your content